Sponsor Pipeline

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
3
Recruiting
1
Phase 3
6
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
1
Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06519370 FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or… Triple Negative Breast Cancer Active, Not Recruiting
Phase 2
NCT05171894 A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With… Port-wine Birthmarks Recruiting
Phase 1
NCT05914545 A Study of FZ-AD004 in Patients With Advanced Solid Tumors Advanced and Metastatic Solid Tumor Recruiting
NCT06424665 A Study of FZ-AD005 in Patients With Advanced Solid Tumors Advanced Solid Tumor, SCLC(Small Cell Lung Cancer) or LCNEC (Large Cell Neuroendocrine Carcinoma) Recruiting
NCT05174637 A Study of FDA018-ADC in Patients With Advanced Solid Tumors Advanced/ Metastatic Solid Tumors Active, Not Recruiting
NCT07455045 A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG) High Grade Glioma (III or IV) Not Yet Recruiting
Disease Areas
Get alerts when Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free